LAB Insider Trading Activity and SEC Form 4 Filings
LAB insider trading summary
Over the past 12 months, insiders at Standard Biotools Inc. (LAB) reported 121 open-market purchases worth $115.5M by 9 insiders and no sales on SEC Form 4. Net insider buying was $115.5M.
Latest LAB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Thomas D. Carey | Insider | Buy | $47K (75,000 @ $0.63) |
| Dec 4, 2025 | Casdin Partners GP, LLC | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Casdin Capital, LLC | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Casdin Private Growth Equity Fund Gp, LLC | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Casdin Private Growth Equity Fund, L.P. | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Eli Casdin | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Casdin Private Growth Equity Fund II GP, LLC | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Casdin Partners Master Fund, L.P. | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 4, 2025 | Casdin Private Growth Equity Fund II, L.P. | Director | Buy | $217K (150,000 @ $1.45) |
| Dec 3, 2025 | Casdin Private Growth Equity Fund, L.P. | Director | Buy | $108K (75,000 @ $1.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.